Summit Financial’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
VCM
VPM
Summit Financial's PFE Position: Q1 2026 in Review
Summit Financial increased its Pfizer (PFE) stake by 20% in Q1 2026, buying an estimated $735K and bringing the position to 168,703 shares worth $4.74M. The position accounts for 0.06% of the portfolio, ranked #330.
Summit Financial first reported a position in PFE in Q2 2021 and has held it in 20 quarters since. 2,939 funds tracked by Wall St. Rank hold PFE as of Q1 2026.
- Summit Financial held 168,703 shares of Pfizer worth $4.74M as of Q1 2026.
- Summit Financial bought 27,596 Pfizer shares in Q1 2026, an estimated $735K.
- Pfizer made up 0.06% of Summit Financial's portfolio in Q1 2026, its #330 holding.
- Summit Financial first reported a position in Pfizer in Q2 2021 and has held it in 20 quarters since.
- 2,939 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.
Based on Summit Financial's 13F filing for Q1 2026, filed 15 May 2026.